Loading
Cancer Related Molecular Pathways / Wnt/β Catenin Signaling in Development and Cancer / Chronic Lymphocytic Leukemia Research · Journal article
Asian Pacific Journal of Cancer Biology · July 13, 2026
Raises a question worth testing. It does not answer one.
This is a computational transcriptomic study proposing that CRISPR-mediated LEF1 knockout in CLL cells triggers compensatory activation of the NF-κB/AP-1 pathway. The analysis identifies differential gene expression patterns and predicted regulatory networks but provides no functional validation, clinical outcome data, or experimental confirmation of the proposed survival mechanism.
Secondary transcriptomic data analysis with differential expression and pathway enrichment. CLL cells with LEF1 inhibition from GEO dataset GSE299964; cell line or primary cell origin not specified. Intervention: CRISPR-Cas9 mediated LEF1 knockout. Compared with: Presumably wild-type or control CLL cells (not explicitly stated).
LEF1 showed significant inhibition with Log2FC of −6.22 following CRISPR-mediated knockout NF-κB/AP-1 pathway activation observed with SLC3A2 upregulation (Log2FC +3.59) and JUN upregulation (Log2FC +3.10) Downregulation of key growth factors CCND1 and MYC observed
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This analysis suggests a potential therapeutic vulnerability in CLL cells that escape LEF1 inhibition through NF-κB pathway activation. However, the findings are purely computational and would require functional studies and clinical validation before informing treatment strategies.
This is a bioinformatic analysis of gene expression data identifying potential compensatory pathways after LEF1 disruption; it raises mechanistic questions rather than testing them functionally or clinically, and requires experimental validation.
As stated by the source record.
Quoted from the source exactly as published.
This analysis suggests a potential therapeutic vulnerability in CLL cells that escape LEF1 inhibition through NF-κB pathway activation. However, the findings are purely computational and would require functional studies and clinical validation before informing treatment strategies.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Background: Chronic lymphocytic leukemia (CLL) remains a major clinical challenge, mainly due to the persistent drug resistance of leukemia- affected cells targeted therapies. The transcription factor gene LEF1, and its governing Wnt/β-catenin axis, is is a well-established driver as a fundamental driver promoting cellular growth and proliferation in this malignancy consequently that we designed this current study to identify the precise compensatory survival mechanism employed by CLL cells following successful disruption of LEF1 signaling. Methods: Gene expression data were obtained from the GEO database (GSE299964) to study and analyzed LEF1inhibition in CLL cell. Differential expression analysis (DEA) and pathway enrichment analysis were used to identify inhibited and activated pathways also was designed a protein-protein interaction network (PPI) to identify and visualize the interaction. Statistical analyses were performed within the R environment (version 4.4.1). Results: By used DEA, the results showed significant inhibition of the Wnt axis (LEF1, Log2FC: -6.22) and concurrent activation of the NF-κB/AP-1 pathway, particularly SLC3A2 (+3.59) and JUN (+3.10). And downregulation in key growth factors was observed specifically CCND1 and MYC. In contrast, the pathway enrichment analysis suggested strong statistical of the NF-kappa B, and an increase in the transcription factors was observed NFKB1 and JUN. It is important that the visualization of the PPI network provided visual evidence the existence of direct regulatory links connecting suppressed Wnt genes to activated NF-kappa B genes, this suggesting a potential emerging therapeutic dependency. Conclusion: The study suggests that the inhibition of the Wnt/LEF1 axis is associated with the potential activation of a compensatory survival mechanism, involving the NF-kappa B/AP-1 pathway. These results indicate that chronic lymphocytic leukemia cells this reciprocal interaction may be used as an adaptive immune response to the disruption of the primary pathway. This aggregation strategy may represent a promising way to address anticipated resistance mechanisms, although further functional and laboratory studies are needed to validate them.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.